Dih Holdings Us Inc (DHAI)
$2.55
+0.09
(+3.66%)▲
Performance
- $2.46$2.67$2.55
3.53%
Downside
Day's Volatility :7.87%
Upside
4.49%
- $0.72$3.67$2.55
71.84%
Downside
52 Weeks Volatility :80.44%
Upside
30.52%
Returns
| Period | Dih Holdings Us Inc | Index (Russel 2000) |
|---|---|---|
3 Months | 39.34% | 0.0% |
6 Months | 189.77% | 0.0% |
1 Year | -76.45% | 0.0% |
3 Years | -74.11% | -22.3% |
Highlights
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | 0.0% |
Return On Equity TTM | 0.0% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | 0.0 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
Analyst Recommendation
Technicals Summary
Sell
Neutral
Buy
Dih Holdings Us Inc is currently in a neutral trading position according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Dih Holdings Us Inc | 12.33% | 189.77% | -76.45% | -74.11% | -74.11% |
 Stryker Corporation | 12.3% | 0.36% | 24.19% | 28.8% | 65.26% |
 Boston Scientific Corp. | 10.6% | 20.32% | 51.42% | 80.93% | 95.5% |
 Edwards Lifesciences Corp. | 9.4% | -28.78% | -12.2% | -45.23% | -7.73% |
 Abbott Laboratories | 3.57% | -5.84% | 13.1% | -11.32% | 35.19% |
 Medtronic Plc | 10.85% | 5.57% | 12.46% | -33.2% | -16.71% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Dih Holdings Us Inc | NA | NA | NA | 0.0 | 0.0 | 0.0 | NA | NA |
Stryker Corporation | 39.84 | 39.84 | 2.64 | 12.0 | 0.19 | 0.07 | 0.01 | 51.86 |
Boston Scientific Corp. | 66.34 | 66.34 | 2.01 | 2.41 | 0.09 | 0.05 | NA | 13.85 |
Edwards Lifesciences Corp. | 26.3 | 26.3 | 3.2 | 2.69 | 0.22 | 0.12 | NA | 12.35 |
Abbott Laboratories | 35.92 | 35.92 | 4.16 | 4.66 | 0.14 | 0.06 | 0.02 | 22.6 |
Medtronic Plc | 30.16 | 30.16 | 1.66 | 5.2 | 0.08 | 0.04 | 0.03 | 37.39 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Dih Holdings Us Inc | NA | $75.4M | -74.11% | NA | 0.0% |
Stryker Corporation | Buy | $136.8B | 65.26% | 39.84 | 16.12% |
Boston Scientific Corp. | Buy | $120.2B | 95.5% | 66.34 | 12.0% |
Edwards Lifesciences Corp. | Buy | $40.2B | -7.73% | 26.3 | 23.74% |
Abbott Laboratories | Buy | $198.1B | 35.19% | 35.92 | 13.65% |
Medtronic Plc | Buy | $115.3B | -16.71% | 30.16 | 12.06% |
Insights on Dih Holdings Us Inc
Decreasing Revenue
Revenue is down for the last 3 quarters, 27.31M → 16.18M (in $), with an average decrease of 22.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 1.95M → -614.0K (in $), with an average decrease of 131.4% per quarter
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 51.4% return, outperforming this stock by 127.9%
Company Information
Organization | Dih Holdings Us Inc |
Employees | 0 |
CEO | Mr. Jason Chen |
Industry | Miscellaneous |
Discover More
A Spac I Acquisition Corp
$2.55
+3.66%
Keyarch Acquisition Corp
$2.55
+3.66%
Connexa Sports Technologies Inc
$2.55
+3.66%
Us Value Etf
$2.55
+3.66%
First Wave Biopharma Inc
$2.55
+3.66%
Global X Msci Next Emerging
$2.55
+3.66%
Fat Projects Acquisition Corp
$2.55
+3.66%
Capital Link Global Fintech
$2.55
+3.66%
Applied Uv Inc
$2.55
+3.66%